ETF

CVS Is Breaking Itself Up. Here’s What That Means for Your Healthcare ETF

CVS just announced a plan to split into two separate public companies, and if you own a healthcare ETF, a dividend fund, or an S&P 500 index fund, your portfolio is already caught in the middle of what happens next.

Published November 4, 2026, 11:33am ET · 4 min read

The ETF Examiner desk. Editor: Ryne Mauck.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A wide-angle exterior view of a CVS/pharmacy store under a clear blue sky. The building has a light beige upper facade and a red brick lower facade, with large red 'CVS/pharmacy' signs displayed prominently on two sides. Red awnings cover several windows below the signs. The entrance features glass doors, and the windows show some interior details and red graphic designs, along with a 'MoneyGram' sign visible in one window.
A CVS/pharmacy store stands as a representation of CVS Health's widespread and diversified healthcare platform, following a strong earnings report. © jetcityimage / iStock Editorial via Getty Images

Shares of CVS Health (NYSE:CVS | CVS Price Prediction) fell 11.03% to $81.33 in Wednesday morning trading. Earlier in the session, the stock reached an intraday low of $77.33. The cause was the company’s plan to split into two publicly traded companies. That split will eventually show up in your portfolio through a healthcare sector ETF, a dividend fund, or an S&P 500 index fund.

CVS price target

What CVS Announced Today

CVS plans to separate into two independent companies and expects to finish the job in the first half of 2028. The healthcare solutions business keeps the CVS Health name. It holds Aetna, the Caremark pharmacy benefit manager, specialty pharmacy, Oak Street, and Signify Health, and David Joyner will lead it as chairman and CEO. The retail company, called CVS Pharmacy, gets the stores, mail order, MinuteClinic, and the Health100 platform. Prem Shah, currently group president of CVS Health, will run it.

A pharmacy benefit manager works for employers and health plans. It negotiates drug prices with manufacturers and processes prescription claims.

After the split, current shareholders are expected to own shares in both companies, and the transaction is expected to be tax-free for U.S. federal income tax purposes. Joyner said the decision was a choice: “We are doing this out of a position of strength. We don’t have to make the decisions.”

Strong Results Didn’t Stop the Selloff

The stock fell on the same day CVS beat expectations. Adjusted EPS came in at $2.09, ahead of the $1.65 consensus. Revenue grew 5.4% to $108.40 billion, exceeding estimates of $104.69 billion. Aetna’s medical benefit ratio, the share of premiums paid out in claims, improved to 91.3% from 92.8%. Management raised its full-year adjusted EPS guidance to at least $8.20 and its operating cash flow guidance to at least $15.5 billion.

CVS earnings explorer

Investors appear focused on what it costs to take apart an integrated model. Management noted one-time separation costs and ongoing public-company costs. Brian Newman said that “the strategic value created by taking this action is going to far outweigh any dis-synergies.”

Which ETFs Own CVS and How Much

The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) had about $40.6 billion in net assets. As of June 30, 2026, CVS made up 2.30% of the fund. At that weight, today’s drop takes about 0.25 percentage points off the fund’s return. XLV was still up 0.86% by mid-morning.

The Vanguard High Dividend Yield ETF (NYSEARCA:VYM) held 5,167,523 CVS shares worth $539.6 million, or 0.54% of net assets, as of July 31. That works out to about 0.06 percentage points of drag. For comparison, VYM’s top holding accounts for 7.35%.

CVS also shows up in the Vanguard Health Care ETF (NYSEARCA:VHT), which charges a 0.09% expense ratio, and in the iShares U.S. Healthcare Providers ETF (NYSEARCA:IHF), which charges 0.37%. Provider-focused funds hold insurers, PBMs, and care delivery companies, so one large name can move them more. The sponsors’ holdings pages list each fund’s current position weights.

CVS analyst ratings

How a Spinoff Works Inside Your Index Fund

When the split closes, every fund that has CVS will automatically receive CVS Pharmacy shares in proportion to its CVS stake. Index providers then decide how to sort and weight each company. The insurance and PBM business fits naturally in healthcare indexes. A retail pharmacy company could be sorted differently, and if it falls outside a fund’s index, the fund has to sell it. That can create temporary selling pressure. Dividend funds will also screen each new company against their yield rules.

None of this is imminent. The deal still needs final board approval, Form 10 effectiveness, and receipt of customary tax confirmation. Until it closes, your funds own the same integrated company they had yesterday.

Check Your Overlap Before 2028

Retirement investors often own CVS several times over: through an S&P 500 fund, a healthcare sector ETF, and a dividend fund. Each position looks small, but together they add up. Your real exposure is the combined total across every account.

Three things to watch between now and 2028:

  • The Form 10 filing, which will lay out each company’s debt, dividend policy, and financials.
  • Index provider announcements on how each company will be sorted.
  • CVS’s progress toward its 2027 adjusted EPS outlook of at least $8.65.

Running an overlap check across your accounts now will show how much CVS you actually own before the split changes the picture.

Contact [email protected] for any questions or corrections.

Ryne Mauck

Ryne Mauck is an investment writer covering exchange-traded funds, retirement planning, and portfolio strategy. Through his work at 24/7 Wall St. and other investment platforms, including Seeking Alpha, he aims to provide clear, research-driven insights that help investors make more informed decisions while maintaining a long-term approach to investing.

Ryne holds a B.Sc. in Finance and an M.A. in Political Science. He is a formerly registered Municipal Advisor Representative and has passed the Series 50, Series 63, and Series 65 exams. His articles are not intended to be, nor should they be interpreted as, financial advice.

All articles →